Our Blog
-
BioUtah Letter on Prioritizing Life Sciences Workers for Vaccine Distribution
December 3, 2020 Mr. Rich Lakin, MSPH, MPA Immunizations Director Utah Department of Health Bureau of Epidemiology PO…
-
ProLung Has a New Name, Gets $3.3 Million Private Placement and More…
ProLung, now IONIQ Sciences (IONIQ), has been on a roll! Last week, the company announced that they had fully…
-
BioUtah Enters M.O.U. with Hangshou Yuhang Economic-Technological Development Area
An MOU was signed between the Hangzhou District, World Trade Center Utah and BioUtah indicating a desire to…
-
Trump May Look to Advance International Pricing Index
Game On: Groups Launch Competing Drug Pricing Ad Campaigns With prospects dim, at least in the short-term, for…
-
Senate Passes USMCA – Heads to the President’s Desk
The Senate on Thursday passed President Trump’s United States-Mexico-Canada Agreement (USMCA) by a wide bipartisan vote of 89-10.…
-
Speakers, Agenda Announced for 2020 Entrepreneur & Investor Life Science Summit
BioUtah/TVC 2020 Entrepreneur & Investor Life Science Summit Salt Lake City, Utah – January 17, 2020 – BioUtah,…
-
Antibiotic-Resistant “Superbugs” – Public Health Crisis and Research Challenge
Antimicrobial Resistance (AMR) is a public health crisis, but developing new classes of antibiotics to combat drug resistant…
-
Positioning on Drug Pricing Continues
Sen. Grassley Calls on Pelosi to Support His Bill Conservative Group Backs GOP Drug Pricing Alternative As we…
-
Red Tape Reduction: FDA Issues List of 510(k) Device Exemptions
On December 30, the FDA issued a notice (see the FDA’s Federal Register notice) that exempts certain class…
-
Congress Reconvenes: Drug Pricing, USMCA updates
Congress returned yesterday with a number of big ticket items on their plate, including drug pricing and the…
-
BioUtah Applauds Passage of Medical Device Tax Repeal
SALT LAKE CITY–(BUSINESS WIRE)–BioUtah applauds congressional action to permanently repeal the 2.3% excise tax on the sale of…